MFS
ADMS

MSI Financial Services’s Adamas Pharmaceuticals ADMS Stock Holding History

MSI Financial Services’s Portfolio ADMS Stock Details ADMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$2K Hold
100
– – ﹤0.01% 3568
2016
Q3 		$2K Hold
100
– – ﹤0.01% 3575
2016
Q2 		$2K Hold
100
– – ﹤0.01% 3591
2016
Q1 		$1K Hold
100
– – ﹤0.01% 3834
2015
Q4 		$3K Hold
100
– – ﹤0.01% 3357
2015
Q3 		$2K Buy
+100
New +$2.27K ﹤0.01% 2827

Other funds holding ADMS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BWCA
Brenner West Capital Advisors New York $804M AUM 16.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

MSI Financial Services's ADMS Position: Q4 2016 in Review

MSI Financial Services held its Adamas Pharmaceuticals (ADMS) position steady in Q4 2016 at 100 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #3568.

MSI Financial Services first reported a position in ADMS in Q3 2015 and has held it in 6 quarters since. The position peaked at $3K in Q4 2015. 78 funds tracked by Wall St. Rank hold ADMS as of Q4 2016.

  • MSI Financial Services held 100 shares of Adamas Pharmaceuticals worth $2K as of Q4 2016.
  • MSI Financial Services left its Adamas Pharmaceuticals share count unchanged in Q4 2016.
  • Adamas Pharmaceuticals made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #3568 holding.
  • MSI Financial Services first reported a position in Adamas Pharmaceuticals in Q3 2015 and has held it in 6 quarters since.
  • MSI Financial Services's Adamas Pharmaceuticals position peaked at $3K in Q4 2015.
  • 78 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.